Skip to main content

Advertisement

Log in

Protective Function of Nicotinamide Against Ketamine-induced Apoptotic Neurodegeneration in the Infant Rat Brain

  • Published:
Journal of Molecular Neuroscience Aims and scope Submit manuscript

Abstract

During development, anesthetics activate neuroapoptosis and produce damage in the central nervous system that leads to several types of neurological disorders. A single dose of ketamine (40 mg/kg) during synaptogenesis in a 7-day-old rat brain activated the apoptotic cascade and caused extensive neuronal cell death in the forebrain. In this study, we investigated the protective effect of nicotinamide against ketamine-induced apoptotic neurodegeneration. After 4 h, neuronal cell death induced by ketamine was associated with the induction of Bax, release of cytochrome c into the cytosol, and activation of caspase-3. One single dose of 1 mg/g nicotinamide was administered to a developing rat and was found to inhibit ketamine-induced neuroapoptosis by downregulating Bax, inhibiting cytochrome c release from mitochondria into cytosol, and inhibiting the expression of activated caspase-3. TUNEL and immunohistochemical analyses showed that ketamine-induced cell death occurred through apoptosis and that it was inhibited by nicotinamide. Fluoro-Jade-B staining demonstrated an increased number of dead cells in the cortex and thalamus after ketamine treatment; treatment with nicotinamide reduced the number of dead cells in these brain regions. Our findings suggest that nicotinamide attenuated ketamine-induced neuronal cell loss in the developing rat brain and is a promising therapeutic and neuroprotective agent for the treatment of neurodevelopmental disorders.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  • Anand KJ, Soriano SG (2004) Anesthetic agents and the immature brain: are these toxic or therapeutic? Anesthesiology 101:527–530

    Article  PubMed  CAS  Google Scholar 

  • Anderson KJ, Miller KM, Fugaccia I, Scheff SW (2005) Regional distribution of Fluoro-Jade B staining in the hippocampus following traumatic brain injury. Exp Neurol 193:125–130

    Article  PubMed  CAS  Google Scholar 

  • Ayoub IA, Lee EJ, Ogilvy C, Flint BM, Maynard KI (1999) Nicotinamide reduces infarction up to two hours after the onset of permanent focal cerebral ischemia in wistar rats. Neurosci Lett 259:21–24

    Article  PubMed  CAS  Google Scholar 

  • Bernardi P, Krauskopf A, Basso E, Petronilli V, Blachly-Dyson E, Di LF et al (2006) The mitochondrial permeability transition from in vitro artifact to disease target. FEBS J 273:2077–2099

    Article  PubMed  CAS  Google Scholar 

  • Bhargava R, Young KD (2007) Procedural pain management patterns in academic pediatric emergency departments. Acad Emerg Med 14:479–482

    PubMed  Google Scholar 

  • Burkle A (2001) PARP-1: a regulator of genomic stability linked with mammalian longevity. Chembiochemistry 2:725–728

    Article  CAS  Google Scholar 

  • Chong ZZ, Lin SH, Maiese K (2002) Nicotinamide modulates mitochondrial membrane potential and cysteine protease activity during cerebral vascular endothelial cell injury. J Vasc Res 39:131–147

    Article  PubMed  CAS  Google Scholar 

  • Chong ZZ, Lin SH, Maiese K (2004) The NAD + precursor nicotinamide governs neuronal survival during oxidative stress through protein kinase B coupled to FOXO3a and mitochondrial membrane potential. J Cereb Blood Flow Metab 24:728–743

    Article  PubMed  CAS  Google Scholar 

  • Chong ZZ, Lin SH, Li F, Maiese K (2005) The sirtuin inhibitor nicotinamide enhances neuronal cell survival during acute anoxic injury through Akt, Bad, PARP, and mitochondrial associate “anti-apoptotic” pathways. Curr Neurovasc Res 2:271–285

    Article  PubMed  CAS  Google Scholar 

  • Hengartner MO (2000) The biochemistry of apoptosis. Nature 407:770–776

    Article  PubMed  CAS  Google Scholar 

  • Ikonomidou C, Bosch F, Miksa M, Bittigau P, Vockler J, Dikranian K et al (1999) Blockade of NMDA receptors and apoptotic neurodegeneration in the developing brain. Science 283:70–74

    Article  PubMed  CAS  Google Scholar 

  • Jevtovic-Todorovic V, Hartman RE, Izumi Y, Benshoff ND, Dikranian K, Zorumski CF et al (2003) Early exposure to common anesthetic agents causes widespread neurodegeneration in the developing rat brain and persistent learning deficits. J Neurosci 23:876–882

    PubMed  CAS  Google Scholar 

  • Johnson KM, Phillips M, Wang C, Kevetter GA (1998) Chronic phencyclidine induces behavioral sensitization and apoptotic cell death in the olfactory and piriform cortex. J Neurosci Res 52:709–722

    Article  PubMed  CAS  Google Scholar 

  • Klaidman LK, Mukherjee SK, Hutchin TP, Adams JD (1996) Nicotinamide as a precursor for NAD + prevents apoptosis in the mouse brain induced by tertiary-butylhydroperoxide. Neurosci Lett 206:5–8

    Article  PubMed  CAS  Google Scholar 

  • Klaidman LK, Mukherjee SK, Adams JD (2001) Oxidative changes in brain pyridine nucleotides and neuroprotection using nicotinamide. Biochim Biophys Acta 1525:136–148

    Article  PubMed  CAS  Google Scholar 

  • Klaidman L, Morales M, Kem S, Yang J, Chang ML, Adams JD (2003) Nicotinamide offers multiple protective mechanisms in stroke as a precursor for NAD+, as a PARP inhibitor and by partial restoration of mitochondrial function. Pharmacology 69:150–157

    Article  PubMed  CAS  Google Scholar 

  • Krauss B, Green SM (2006) Procedural sedation and analgesia in children. Lancet 367:766–780

    Article  PubMed  CAS  Google Scholar 

  • Laraci A, Herrera DG (2006) Nicotinamide protects against ethanol-induced apoptotic neurodegeneration in the developing mouse brain. PLoS Med 3:547–557

    Article  Google Scholar 

  • Li P, Nijhawan D, Budihardjo I, Srinivasula SM, Ahmad M, Alnemri ES et al (1997) Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell 91:479–489

    Article  PubMed  CAS  Google Scholar 

  • Maiese K, Chong ZZ (2003) Nicotinamide: necessary nutrient emerges as a novel cytoprotectant for the brain. Trends Pharmacol Science 24:228–232

    Article  CAS  Google Scholar 

  • Mukherjee SK, Klaidman LK, Yasharel R, Adams JD (1997) Increased brain NAD prevents neuronal apoptosis in vivo. Eur J Pharmacol 330:27–34

    Article  PubMed  CAS  Google Scholar 

  • Mukherjee S, Sonee M, Adams JD (2005) A review of the regulatory role of nicotinamide on pro- and anti-apoptotic proteins in neuronal cells. Lett Drug Des Discov 2:551–557

    Article  CAS  Google Scholar 

  • Olney JW, Tenkova T, Dikranian K, Muglia LJ, Jermakowicz WJ, D’Sa C et al (2002) Ethanol-induced caspase-3 activation in the in vivo developing mouse brain. Neurobiol Dis 9:205–219

    Article  PubMed  CAS  Google Scholar 

  • O’Rourke B, Cortassa S, Aon MA (2005) Mitochondrial ion channels: gatekeepers of life and death. Physiology 20:303–315

    Article  PubMed  Google Scholar 

  • Rupinder SK, Gurpreet AK, Manjeet S (2007) Cell suicide and caspases. Vascul Pharmacol 46:383–393

    Article  PubMed  CAS  Google Scholar 

  • Sas K, Robotka H, Rozsa E, Agoston M, Szenasi G, Gigler G et al (2008) Kynurenine diminishes the ischemia-induced histological and electrophysiological deficits in the rat hippocampus. Neurobiol Dis 32:302–308

    Article  PubMed  CAS  Google Scholar 

  • Scallet AC, Schmued LC, Slikker W, Grunberg N, Faustino PJ, Davis H et al (2004) Developmental neurotoxicity of ketamine: morphometric confirmation, exposure parameters, and multiple fluorescent labeling of apoptotic neurons. Toxicol Sci 81:364–370

    Article  PubMed  CAS  Google Scholar 

  • Slikker W, Xu Z, Wang C (2005) Application of a systems biology approach to developmental neurotoxicology. Reprod Toxicol 19:305–319

    Article  PubMed  CAS  Google Scholar 

  • Slikker W, Zou X, Hotchkiss CE, Divine RL, Sadovova N, Twaddle NC et al (2007) Ketamine-induced neurodegeneration in the perinatal rhesus monkey. Toxicol Sci 98:145–158

    Article  PubMed  CAS  Google Scholar 

  • Ungerstedt JS, Blomback M, Soderdtom T (2003) Nicotinamide is a potent inhibitor of proinflammatory cytokines. Clin Exp Immunol 131:48–52

    Article  PubMed  CAS  Google Scholar 

  • Wang C, Kaufmann JA, Sanchez-Ross MG, Johnson KM (2000) Mechanisms of N methyl-d-aspartate-induced apoptosis in phencyclidine treated cultured forebrain neurons. J Pharmacol Exp Ther 294:287–295

    PubMed  CAS  Google Scholar 

  • Wang C, Sadovova N, Fu X, Schmued L, Scallet A, Hanig J et al (2005) The role of the N-methyl-d-aspartate receptor in ketamine-induced apoptosis in rat forebrain culture. Neuroscience 132:967–977

    Article  PubMed  CAS  Google Scholar 

  • Wang C, Sadovova N, Hotchkiss C, Fu X, Scallet AC, Patterson TA et al (2006) Blockade of N-methyl-d-aspartate receptors by ketamine produces loss of postnatal day 3 monkey frontal cortical neurons in culture. Toxicol Sci 91:192–201

    Article  PubMed  CAS  Google Scholar 

  • Wozniak DF, Hartman RE, Boyle MP, Vogt SK, Brooks AR, Tenkova T et al (2004) Apoptotic neurodegeneration induced by ethanol in neonatal mice is associated with profound learning/memory deficits in juveniles followed by progressive functional recovery in adults. Neurobiol Dis 17:403–414

    Article  PubMed  CAS  Google Scholar 

  • Yang J, Klaidman LK, Chang ML, Kem S, Sugawara T, Chan P et al (2002a) Nicotinamide therapy protects against both necrosis and apoptosis in a stroke model. Pharmacol Biochem Behav 73:901–910

    Article  PubMed  CAS  Google Scholar 

  • Yang J, Klaidman LK, Nalbandian A, Oliver J, Chang ML, Chan PH et al (2002b) The effects of nicotinamide on energy metabolism following transient focal cerebral ischemia in Wistar rats. Neurosci Lett 333:91–94

    Article  PubMed  CAS  Google Scholar 

  • Young C, Roth KA, Klocke BJ, West T, Holtzman DM, Labruyere J et al (2005) Role of caspase-3 in ethanol-induced developmental neurodegeneration. Neurobiol Dis 20:608–614

    Article  PubMed  CAS  Google Scholar 

  • Zamzami N, Kroemer G (2001) The mitochondrion in apoptosis: how Pandora’s box opens. Nat Rev Mol Cell Biol 2:67–71

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

This work was supported by Rural Development Administration (Agenda: PJ007361) and Next-Generation Biogreen 21 program (PJ008075) funded by the Korean government.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Myeong Ok Kim.

Additional information

Najeeb Ullah, Ikram Ullah and Hae Young Lee contributed equally to this work.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ullah, N., Ullah, I., Lee, H.Y. et al. Protective Function of Nicotinamide Against Ketamine-induced Apoptotic Neurodegeneration in the Infant Rat Brain. J Mol Neurosci 47, 67–75 (2012). https://doi.org/10.1007/s12031-011-9685-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12031-011-9685-1

Keywords

Navigation